Naoya Morishita

Sequential Changes in Laminin and Type IV Collagen in the Infarct Zone

Naoya Morishita, Shozo Kusachi, Satoshi Yamasaki et al. · Japanese Circulation Journal · 1996 · 38 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +15

Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice

Saki Takei, Chika Omoto, Koichi Kitagawa et al. · Vaccine · 2014 · 32 citations

Life Sciences, Immunology, Microbiology +10

Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines

Zainal Adhim, Naoki Otsuki, Junko Kitamoto et al. · Acta Oto-Laryngologica · 2013 · 22 citations

Medicine, Molecular Biology, Oncology +15

A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma.

Hiroki Saito, Satoshi Ando, Naoya Morishita et al. · PubMed · 2014 · 15 citations

Life Sciences, Immunology, Oncology +14

E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma

Zainal Adhim, Xubin Lin, Wei Huang et al. · Cancer Gene Therapy · 2011 · 14 citations · Full text

Medicine, Oncology, Pharmacology +9